Novo Nordisk's weight loss pill could give the company's numbers a big boost this year.

ALLEROD, Denmark, Jan 30 (Reuters) - A play examining the meteoric rise of Danish weight-loss drug giant Novo Nordisk will ...

Danish pharmaceutical giant Novo Nordisk (NVO) has seen a strong rebound at the start of 2026, following two consecutive ...

The target action date for orforglipron is now April 10.

Medicines and Healthcare products Regulatory Agency experts have issued a stern warning over two particular brands ...

By Bhanvi Satija and Maggie Fick LONDON, Jan 16 (Reuters) - Novo Nordisk's Wegovy weight-loss pill has made an encouraging ...

The oral weight-loss drug introduced by Novo Nordisk this year in the U.S. is quickly being adopted.

Two weeks after securing approval from the U.S. Food and Drug Administration, a once-daily pill version of Novo Nordisk‘s popular GLP-1 weight loss drug Wegovy officially hit the market. In a Jan. 5 ...

Novo Nordisk announced Jan. 5 it will begin offering its Wegovy weight loss pill to self-paying patients in the United States, expanding access to the popular GLP-1 medication beyond injections. The ...

According to the Centers for Disease Control and Prevention, 41.9 percent of U.S. adults were obese from 2017 to 2020.